Here’s the latest instalment of our news updates from Blackford Platform Partners. As you can imagine, the COVID-19 pandemic features significantly in many of the updates.
In a recent
open letter, the CEO of medical 3D printing specialist
axial3D revealed the company is evaluating and prototyping various 3D printed devices, parts, and equipment that would help in tackling the COVID-19 outbreak. The firm
announced this week that it has begun producing face shields that can be used by frontline workers, the first batches of which have already been dispatched. Fresh on heels of
announcing $11M in Series C funding to support the growth of its LungPrint solution, our lung imaging analysis partner
VIDA
revealed it is working to assist in the fight against COVID-19. The company is actively working with researchers, clinicians, and therapy providers on several COVID-19 programs. The people at
icometrix have also been working hard on COVID-19 solutions, announcing
icovid - an algorithm for the quantification of lung damage in COVID-19 patients. The company also launched its free
icompanion app earlier than planned with the aim to help with the remote monitoring of patients with Multiple Sclerosis during periods of social distancing. And finally, innovative medical diagnostic provider
MaxQ AI highlighted an
interview with a neurologist at the Kaiser Permanente Medical Center in Los Angeles, who shares insight into how AI-powered diagnostic solutions can support the detection of intracranial hemorrhage. The company also revealed that is has been
listed by ISRAEL21C as one of the top 10 Israeli companies scouring data to save lives.
Stay tuned for more partner news next month!